These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12889995)

  • 1. Expression and function of HLA-DR3 and DQ8 in transgenic mice lacking functional H2-M.
    Rajagopalan G; Smart MK; Cheng S; Krco CJ; Johnson KL; David CS
    Tissue Antigens; 2003 Aug; 62(2):149-61. PubMed ID: 12889995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression and function of transgenic HLA-DQ molecules and lymphocyte development in mice lacking invariant chain.
    Rajagopalan G; Smart MK; Krco CJ; David CS
    J Immunol; 2002 Aug; 169(4):1774-83. PubMed ID: 12165499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcal enterotoxin B-induced activation and concomitant resistance to cell death in CD28-deficient HLA-DQ8 transgenic mice.
    Rajagopalan G; Smart MK; Marietta EV; David CS
    Int Immunol; 2002 Jul; 14(7):801-12. PubMed ID: 12096040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Concomitant Disruption of
    Chowdhary VR; Krogman A; Tilahun AY; Alexander MP; David CS; Rajagopalan G
    J Immunol; 2017 Jun; 198(11):4413-4424. PubMed ID: 28468970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo evaluation of staphylococcal superantigen peptide antagonists.
    Rajagopalan G; Sen MM; David CS
    Infect Immun; 2004 Nov; 72(11):6733-7. PubMed ID: 15501813
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DQ8 (DQB1*0302)-restricted Th17 cells exacerbate experimental autoimmune encephalomyelitis in HLA-DR3-transgenic mice.
    Mangalam A; Luckey D; Basal E; Jackson M; Smart M; Rodriguez M; David C
    J Immunol; 2009 Apr; 182(8):5131-9. PubMed ID: 19342694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of insulitis and type 1 diabetes by transgenic HLA-DR3 and DQ8 in NOD mice lacking endogenous MHC class II.
    Kudva YC; Rajagopalan G; Raju R; Abraham RS; Smart M; Hanson J; David CS
    Hum Immunol; 2002 Nov; 63(11):987-99. PubMed ID: 12392851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HLA-DO increases bacterial superantigen binding to human MHC molecules by inhibiting dissociation of class II-associated invariant chain peptides.
    Pezeshki AM; Azar GA; Mourad W; Routy JP; Boulassel MR; Denzin LK; Thibodeau J
    Hum Immunol; 2013 Oct; 74(10):1280-7. PubMed ID: 23756162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoimmune diabetes in HLA-DR3/DQ8 transgenic mice expressing the co-stimulatory molecule B7-1 in the beta cells of islets of Langerhans.
    Rajagopalan G; Kudva YC; Chen L; Wen L; David CS
    Int Immunol; 2003 Sep; 15(9):1035-44. PubMed ID: 12917255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coexpression of susceptible and resistant HLA class II transgenes in murine experimental autoimmune thyroiditis: DQ8 molecules downregulate DR3-mediated thyroiditis.
    Flynn JC; Wan Q; Panos JC; McCormick DJ; Giraldo AA; David CS; Kong YC
    J Autoimmun; 2002 May; 18(3):213-20. PubMed ID: 12126634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformational alterations during biosynthesis of HLA-DR3 molecules controlled by invariant chain and HLA-DM.
    Verreck FA; Fargeas CA; Hämmerling GJ
    Eur J Immunol; 2001 Apr; 31(4):1029-36. PubMed ID: 11298327
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA Class II Polymorphisms Modulate Gut Microbiota and Experimental Autoimmune Encephalomyelitis Phenotype.
    Shahi SK; Ali S; Jaime CM; Guseva NV; Mangalam AK
    Immunohorizons; 2021 Aug; 5(8):627-646. PubMed ID: 34380664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intranasal exposure to bacterial superantigens induces airway inflammation in HLA class II transgenic mice.
    Rajagopalan G; Iijima K; Singh M; Kita H; Patel R; David CS
    Infect Immun; 2006 Feb; 74(2):1284-96. PubMed ID: 16428778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Type 1 diabetes associated HLA-DQ2 and DQ8 molecules are relatively resistant to HLA-DM mediated release of invariant chain-derived CLIP peptides.
    Zhou Z; Reyes-Vargas E; Escobar H; Rudd B; Rockwood AL; Delgado JC; He X; Jensen PE
    Eur J Immunol; 2016 Apr; 46(4):834-45. PubMed ID: 26707565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HLA-DR and HLA-DQ polymorphism in human thyroglobulin-induced autoimmune thyroiditis: DR3 and DQ8 transgenic mice are susceptible.
    Wan Q; Shah R; Panos JC; Giraldo AA; David CS; Kong Yc
    Hum Immunol; 2002 Apr; 63(4):301-10. PubMed ID: 12039412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 320-kilobase artificial chromosome encoding the human HLA DR3-DQ2 MHC haplotype confers HLA restriction in transgenic mice.
    Chen Z; Dudek N; Wijburg O; Strugnell R; Brown L; Deliyannis G; Jackson D; Koentgen F; Gordon T; McCluskey J
    J Immunol; 2002 Mar; 168(6):3050-6. PubMed ID: 11884478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the role of HLA-DQ polymorphisms on immune response to bacterial superantigens using transgenic mice.
    Rajagopalan G; Polich G; Sen MM; Singh M; Epstein BE; Lytle AK; Rouse MS; Patel R; David CS
    Tissue Antigens; 2008 Feb; 71(2):135-45. PubMed ID: 18086265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Major histocompatibility complex class II-associated peptides determine the binding of the superantigen toxic shock syndrome toxin-1.
    von Bonin A; Ehrlich S; Malcherek G; Fleischer B
    Eur J Immunol; 1995 Oct; 25(10):2894-8. PubMed ID: 7589089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vivo staphylococcal superantigen-driven polyclonal Ig responses in mice: dependence upon CD4(+) cells and human MHC class II.
    Stohl W; Xu D; Zang S; Kim KS; Li L; Hanson JA; Stohlman SA; David CS; Jacob CO
    Int Immunol; 2001 Oct; 13(10):1291-300. PubMed ID: 11581174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diverse repertoire of the MHC class II-peptide complexes is required for presentation of viral superantigens.
    Golovkina T; Agafonova Y; Kazansky D; Chervonsky A
    J Immunol; 2001 Feb; 166(4):2244-50. PubMed ID: 11160278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.